On Invalid Date, Adicet Bio (NASDAQ: ACET) reported Q1 2023 earnings per share (EPS) of -$0.72, up 700% year over year. Total Adicet Bio earnings for the quarter were -$30.88 million. In the same quarter last year, Adicet Bio's earnings per share (EPS) was $0.12.
As of Q2 2023, Adicet Bio's earnings has grown year over year. Adicet Bio's earnings in the past year totalled -$105.29 million.
What was ACET's revenue last quarter?
On Invalid Date, Adicet Bio (NASDAQ: ACET) reported Q1 2023 revenue of $0.00 up 100% year over year. In the same quarter last year, Adicet Bio's revenue was $24.99 million.
What was ACET's revenue growth in the past year?
As of Q2 2023, Adicet Bio's revenue has grown -100% year over year. This is 169.78 percentage points lower than the US Biotechnology industry revenue growth rate of 69.78%. Adicet Bio's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.